LIBIVIRUMAB
UNII J1R33H8X7A

Substance Identification & Data

This profile provides standardized clinical and technical data for Libivirumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J1R33H8X7A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 569658-79-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
J1R33H8X7A
CAS Registry Number
569658-79-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIBIVIRUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C170122
National Cancer Institute reference terminology for clinical and research data.
INN ID
8481
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Libivirumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIBIVIRUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G, ANTI-(HEPATITIS B SURFACE ANTIGEN) (HUMAN MONOCLONAL 17.1.41 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 17.1.41 .KAPPA.-CHAIN, DIMER
LIBIVIRUMAB [INN]
LIBIVIRUMAB [WHO-DD]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus